Hoxworth Blood Center calls for Type O donors, offering free Cyclones tickets
Hoxworth Blood Center, University of Cincinnati is seeking type O donors to help replenish the local blood supply.
Donor with Type O+ or O- that donate at one of Hoxworth’s seven Neighborhood Donor Centers from Monday, Feb. 24 through Wednesday, Feb. 26 will receive a voucher for two Cincinnati Cyclones hockey tickets (while supplies last).
“We always say that the rarest blood type is the blood that isn’t on the shelf when you need it,” said Alecia Lipton, spokesperson for Hoxworth. “But we know that when we put out the call, our Cincinnati community will come together to help us rebuild the blood supply — and this time, we are excited to offer our lifesaving Type O donors free Cyclones tickets as a thank you for making a special trip to donate.”
According to Lipton, it is critical to have a stable supply of Type O+ and O- blood on the shelf, since these types can be transfused to most people in an emergency. Lipton also noted that Hoxworth Blood Center needs to collect 400 units of blood and 50 units of platelets a day to keep up with the demand of local hospitals.
Ticket vouchers are available while supplies last, so appointments are highly encouraged, though walk-ins are welcome. Donors can schedule appointments by calling (513) 451-0910 or by scheduling online at: www.hoxworth.org.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.